Using flow cytometry, we found that CD79b+ neutrophils expressed higher levels of the antigen presentation-related proteins, namely CD40, CD80, and HLA-DR, compared to other neutrophils in melanoma subjects (Figure 5C). This evidence concerns the gene CD79B and melanoma.